ALT
Altimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.42
+5.88%Leverage
- Debt / equity
- 0.08x
- Net debt / equity
- -0.06x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -0.39x
- Net debt / EBITDA
- 0.29x
Liquidity & coverage
- Current ratio
- 26.78x
- Quick ratio
- 26.78x
- Cash ratio
- 26.10x
- Interest coverage
- -28.34x
- EBITDA / interest
- -26.19x
- Working capital
- $322.3M
Cash & dividend
- FCF / debt
- -2.14x
- Cash flow / debt
- -2.14x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026